Epoprostenol beneficial in primary pulmonary hypertension

被引：0
|
作者：
Bonn, D
机构：
来源：
LANCET | 1997年 / 350卷 / 9075期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：417 / 417
页数：1
相关论文
共 50 条
  • [1] Epoprostenol in primary pulmonary hypertension
    Herner, SJ
    Mauro, LS
    [J]. ANNALS OF PHARMACOTHERAPY, 1999, 33 (03) : 340 - 347
  • [2] Intravenous epoprostenol for primary pulmonary hypertension
    Higenbottam, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (22): : 1477 - 1477
  • [3] Survival in primary pulmonary hypertension - The impact of epoprostenol therapy
    McLaughlin, VV
    Shillington, A
    Rich, S
    [J]. CIRCULATION, 2002, 106 (12) : 1477 - 1482
  • [4] Epoprostenol and gas exchange in primary pulmonary hypertension.
    Mazzone, P
    Rafanan, AL
    Lakowski, D
    Hague, K
    Maurer, J
    Mehta, AC
    Schilz, R
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A162 - A162
  • [5] Epoprostenol (prostacyclin) therapy in primary pulmonary hypertension - Reply
    Rich, S
    McLAughlin, VV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (24): : 1773 - 1774
  • [6] Pregnancy and primary pulmonary hypertension - Successful outcome with epoprostenol therapy
    Stewart, R
    Tuazon, D
    Olson, G
    Duarte, AG
    [J]. CHEST, 2001, 119 (03) : 973 - 975
  • [7] Micrococcal bacteremia in patients with primary pulmonary hypertension on epoprostenol.
    Ehrensing, ER
    Stamm, AM
    Aaron, MF
    Bourge, RC
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1998, 19 (09): : 696 - 696
  • [8] TREATMENT OF PRIMARY PULMONARY-HYPERTENSION WITH INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN)
    JONES, DK
    HIGENBOTTAM, TW
    WALLWORK, J
    [J]. BRITISH HEART JOURNAL, 1987, 57 (03): : 270 - 278
  • [9] Oral sildenatil improves primary pulmonary hypertension refractory to epoprostenol
    Kataoka, M
    Satoh, T
    Manabe, T
    Anzai, T
    Yoshikawa, T
    Mitamura, H
    Ogawa, S
    [J]. CIRCULATION JOURNAL, 2005, 69 (04) : 461 - 465
  • [10] Efficacy and safety of treprostinil: An Epoprostenol analog for primary pulmonary hypertension
    McLaughlin, VV
    Gaine, SP
    Barst, RJ
    Oudiz, RJ
    Bourge, RC
    Frost, A
    Robbins, IM
    Tapson, VF
    McGoon, MD
    Badesch, DB
    Sigman, J
    Roscigno, R
    Blackburn, SD
    Arneson, C
    Rubin, LJ
    Rich, S
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 41 (02) : 293 - 299
12345